Abstract:Background: The second wave of the COVID-19 pandemic was more aggressive in Brazil compared to other countries around the globe. Considering the Brazilian peculiarities, we analyze the in-hospital mortality concerning socio-epidemiological characteristics of patients and the health system of all states during the first and second waves of COVID-19. Methods: We performed a cross-sectional study of hospitalized patients with positive RT-PCR for SARS-CoV-2 in Brazil. Data was obtained from the Influenza Epidemiological Surveillance Information System (SIVEP-Gripe) and comprised the period from February 25, 2020, to April 30, 2021, separated in two waves on November 5, 2020. We performed a descriptive study of patients analyzing socio-demographic characteristics, symptoms, comorbidities, and risk factors stratified by age. In addition, we analyzed in-hospital and intensive care unit (ICU) mortality in both waves and how it varies in each Brazilian state.Findings: Between February 25, 2020 and April 30, 2021, 678 235 patients were admitted with a positive RT-PCR for SARS-CoV-2, with 325 903 and 352 332 patients for the first and second wave, respectively. The mean age of patients was 59$.65 (IQR 48.0 - 72.0). In total, 379 817 (56.00%) patients had a risk factor or comorbidity. The most common symptoms at hospital admission were dyspnea, cough, and oxygen saturation <95%. In-hospital mortality increased from 34.81% in the first to 39.30% in the second wave. In the second wave, there were more ICU admissions, use of non-invasive and invasive ventilation, and increased mortality for younger age groups. The southern and southeastern regions of Brazil had the highest hospitalization rates per 100 000 inhabitants. However, the in-hospital mortality rate was higher in the northern and northeastern states of the country. Racial differences were observed in clinical outcomes, with white being the most prevalent hospitalized population, but with blacks/browns having higher mortality rates. Younger age groups had more significant differences in mortality as compared to groups with and without comorbidities in both waves.Interpretation: We observed a more significant burden on the Brazilian hospital system throughout the second wave. Furthermore, a greater number of hospital beds was not able to reduce mortality, and the north and northeast of Brazil, which present lower Human Development Indexes, concentrated the worst in-hospital mortality rates. The highest mortality rates are also shown among vulnerable social groups. Finally, we believe that the results can help to understand the behavior of the COVID-19 pandemic in Brazil, helping to define public policies, allocate resources, and improve strategies for vaccination of priority groups.Funding Information: The authors would like to thank the Coordinating Agency for Advanced Training of Graduate Personnel (CAPES) (C.F. 001) and the National Council for Scientific and Technological Development (CNPq) (No. 309537/2020-7).Declaration of Interests: We declare no competing interests.Ethics Approval Statement: Following ethically agreed principles on open data, this analysis did not require ethical approval in Brazil.

Diversity of Omicron sublineages and clinical characteristics in hospitalized patients in the southernmost state of Brazil

Epidemiology of the SARS-CoV-2 Omicron Variant Emergence in the Southeast Brazilian Population

Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification

Higher frequency of interstate over international transmission chains of SARS-CoV-2 virus at the Rio Grande do Sul - Brazil state borders

Intense P.1 (Gamma) diversification followed by rapid Delta substitution in Southern Brazil: a SARS-CoV-2 genomic epidemiology study

Influenza outbreak during the surge of SARS‐CoV‐2 omicron in a metropolitan area from southern Brazil: genomic surveillance

Evidence of SARS-CoV-2 JN.2.5 variant circulation in Rio de Janeiro, Brazil

Viral coinfection in hospitalized patients during the COVID-19 pandemic in Southern Brazil: a retrospective cohort study

Genomic surveillance and serological profile of SARS-CoV-2 variants circulating in Macaé and nearby cities, southeastern Brazil

Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil

Rapid spread of the SARS-CoV-2 Omicron XDR lineage derived from recombination between XBB and BA.2.86 subvariants circulating in Brazil in late 2023

Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023

Clinical, epidemiological, and molecular characteristics of SARS-CoV-2 Infections among healthcare workers at a research center in the amazon region of BRAZIL from 2020 to 2022

Genomic monitoring unveils a high prevalence of severe acute respiratory syndrome coronavirus 2 Omicron variant in vaccine breakthrough cases in Bahia, Brazil

Assessing the Clinical Impact of the SARS-CoV-2 Gamma Variant on Intensive Care Unit Admissions: Insights from a Reference Hospital in Northeastern Brazil

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil

First and Second COVID-19 Waves in Brazil: A Cross-Sectional Study of Patients’ Characteristics Related to In-Hospital Mortality

Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

Omicron BA.2 lineage predominance in severe acute respiratory syndrome coronavirus 2 positive cases during the third wave in North India

MONITORING OF RESPIRATORY VIRUS COINFECTION IN SOUTHERN BRAZIL DURING COVID-19 PANDEMIC

Relative frequency of genomic mutations in SARS-CoV-2 recovered from southern Brazilian cases of COVID-19 through the Gamma, Delta and Omicron waves